FDA Advisers Vote Against Experimental ALS Treatment

The panel of Food and Drug Administration experts voted 17-1 that drugmaker Brainstorm's stem cell-based treatment has not been shown effective for patients with the fatal, muscle-wasting disease known as ALS.
Source: Arkansas Business - Health Care - Category: American Health Source Type: news